These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 16208150

  • 1. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
    Dahlöf B, Gosse P, Guéret P, Dubourg O, de Simone G, Schmieder R, Karpov Y, García-Puig J, Matos L, De Leeuw PW, Degaute JP, Magometschnigg D, PICXEL Investigators.
    J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N, Mallion JM, O'Rourke MF, O'Brien E, Rahn KH, Trimarco B, Romero R, De Leeuw PW, Hitzenberger G, Battegay E, Duprez D, Sever P, Safar ME.
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [Abstract] [Full Text] [Related]

  • 6. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
    Mogensen CE, Viberti G, Halimi S, Ritz E, Ruilope L, Jermendy G, Widimsky J, Sareli P, Taton J, Rull J, Erdogan G, De Leeuw PW, Ribeiro A, Sanchez R, Mechmeche R, Nolan J, Sirotiakova J, Hamani A, Scheen A, Hess B, Luger A, Thomas SM, Preterax in Albuminuria Regression (PREMIER) Study Group.
    Hypertension; 2003 May; 41(5):1063-71. PubMed ID: 12654706
    [Abstract] [Full Text] [Related]

  • 7. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C, Lengyel M, Borbás S, Zorándi A, Dienes BS, VERITAS Investigators.
    Curr Med Res Opin; 2003 May; 19(3):205-17. PubMed ID: 12803735
    [Abstract] [Full Text] [Related]

  • 8. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P, Dubourg O, Guéret P, De Simone G, Schmieder R, De Leeuw PW, Degaute JP, García Puig J, Karpov Y, Magometschnigg D, Matos L, Amouyel P, Asmar R, Le Heuzey JY, Nieminen M, Dahlöf B.
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
    Pella D.
    High Blood Press Cardiovasc Prev; 2011 Sep 01; 18(3):107-13. PubMed ID: 21950782
    [Abstract] [Full Text] [Related]

  • 13. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B.
    J Hum Hypertens; 2005 Jun 01; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H, Risler T, Trenkwalder P.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1849-58. PubMed ID: 16968588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Left ventricular hypertrophy regression: the LIVE trial.
    Sheridan DJ.
    Cardiologia; 1999 Dec 01; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.